Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals
- PMID: 21798757
- DOI: 10.1016/j.cyto.2011.06.018
Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals
Abstract
Associations between five polymorphisms of vascular endothelial growth factor (i.e., VEGF +936C/T, -1154A/G, -2578C/A, -634G/C and -460T/C) and risk of breast cancer have been extensively studied, and the currently available results are inconclusive. Therefore, we performed this meta-analysis to further study the associations. The databases of Pubmed, Embase and CNKI were retrieved up to April 1st, 2010. The pooled ORs and 95% CIs were used to assess the strength of the associations. A total of 10 case-control studies with 8175 cases and 8528 controls were included in this study. The overall results of combined analyses showed that five polymorphisms of VEGF were not associated with risk of breast cancer [ORs (95% CIs): 1.03 (0.84-1.27) for CC vs. TT for +936C/T, 0.95 (0.81-1.12) for AA vs. GG for -1154A/G, 1.01 (0.90-1.14) for CC vs. AA for -2578C/A, 1.02 (0.90-1.16) for GG vs. CC for -634G/C and 0.86 (0.68-1.09) for TT vs. CC for -460T/C]. When subgroup analyses by ethnicity for VEGF +936C/T and -634G/C, the results suggested that +936C/T was not associated with the risk of breast cancer for either Asians [1.40 (0.92-2.13) for CC vs. TT and CC+CT vs. TT: 1.38 (0.91-2.10) for CC+CT vs. TT] or Caucasians [0.93 (0.73-1.19) for CC vs. TT and 0.91 (0.72-1.16) for CC+CT vs. TT], and -634G/C was not associated with the breast cancer for Caucasians [1.07 (0.92-1.24) for GG vs. CC and 1.05 (0.91-1.21) for GG+GC vs. CC]. In addition, when excluding one study, which was out of Hardy-Weinberg equilibrium for VEGF +963C/T and whose controls were from both patients and healthy people, the negative results were also persistent, and ORs (95% CIs) were 1.04 (0.84-1.29) for CC vs. TT, 1.03 (0.83-1.27) for (CC+CT) vs. TT. This meta-analysis suggests that the VEGF +936C/T, -1154A/G, -2578C/A, -634G/C and -460T/C may be not associated with risk of breast cancer development based on the currently available studies, especially for Caucasians. More well designed studies with larger sample size on different ethnicities are needed to further assess the associations.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Comment in
-
Need for clarification of data in a recent meta-analysis on vascular endothelial growth factor (VEGF) and risk of breast cancer.Cytokine. 2012 Dec;60(3):596. doi: 10.1016/j.cyto.2012.08.030. Epub 2012 Sep 23. Cytokine. 2012. PMID: 23010501 No abstract available.
Similar articles
-
VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls.Breast Cancer Res Treat. 2011 Jan;125(2):489-93. doi: 10.1007/s10549-010-0991-z. Epub 2010 Jun 19. Breast Cancer Res Treat. 2011. PMID: 20563637
-
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143151
-
The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.Gene. 2013 Sep 15;527(1):95-101. doi: 10.1016/j.gene.2013.05.059. Epub 2013 Jun 4. Gene. 2013. PMID: 23747396
-
Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.Breast Cancer Res Treat. 2010 Jul;122(2):503-7. doi: 10.1007/s10549-009-0717-2. Epub 2010 Jan 6. Breast Cancer Res Treat. 2010. PMID: 20052535 Review.
-
The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.Gene. 2021 Feb 15;769:145187. doi: 10.1016/j.gene.2020.145187. Epub 2020 Sep 28. Gene. 2021. PMID: 32998046 Review.
Cited by
-
Association between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis.Iran J Med Sci. 2015 Jan;40(1):2-12. Iran J Med Sci. 2015. PMID: 25649829 Free PMC article. Review.
-
The role of vascular endothelial growth factor a polymorphisms in breast cancer.Int J Mol Sci. 2012 Nov 13;13(11):14845-64. doi: 10.3390/ijms131114845. Int J Mol Sci. 2012. PMID: 23203097 Free PMC article. Review.
-
Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia.Asian Pac J Cancer Prev. 2020 Jan 1;21(1):139-145. doi: 10.31557/APJCP.2020.21.1.139. Asian Pac J Cancer Prev. 2020. PMID: 31983176 Free PMC article.
-
Association Between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian Population.Breast Cancer (Auckl). 2016 Jul 4;10:85-91. doi: 10.4137/BCBCR.S39649. eCollection 2016. Breast Cancer (Auckl). 2016. PMID: 27398026 Free PMC article.
-
Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.PLoS One. 2013 Oct 1;8(10):e75123. doi: 10.1371/journal.pone.0075123. eCollection 2013. PLoS One. 2013. PMID: 24098368 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous